Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Simon

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2016
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patientsEsther M van Wezel, Boris Decarolis, Janine Stutterheim, et al.
Klinische Padiatrie|June 1, 2017
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic TumorsThorsten Simon, Barbara Hero, Johannes H Schulte, et al.
Cancers|May 14, 2022
Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular DiagnosticsMarco Lodrini, Jasmin Wünschel, Theresa M Thole-Kliesch, et al.
Pediatric Blood & Cancer|February 27, 2018
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?Melina Heinemann, Andreas Ranft, Thorsten Langer, et al.
Frontiers in Oncology|February 8, 2021
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg RegistryDanny Jazmati, Sarina Butzer, Barbara Hero, et al.
Frontiers in Oncology|March 10, 2025
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohortJose Lozano-Montoya, Ana Jimenez-Pastor, Almudena Fuster-Matanzo, et al.
Cancer Letters|June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspectsBruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2016
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patientsEsther M van Wezel, Boris Decarolis, Janine Stutterheim, et al.
Klinische Padiatrie|June 1, 2017
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic TumorsThorsten Simon, Barbara Hero, Johannes H Schulte, et al.
Cancers|May 14, 2022
Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular DiagnosticsMarco Lodrini, Jasmin Wünschel, Theresa M Thole-Kliesch, et al.
Pediatric Blood & Cancer|February 27, 2018
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?Melina Heinemann, Andreas Ranft, Thorsten Langer, et al.
Frontiers in Oncology|February 8, 2021
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg RegistryDanny Jazmati, Sarina Butzer, Barbara Hero, et al.
Frontiers in Oncology|March 10, 2025
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohortJose Lozano-Montoya, Ana Jimenez-Pastor, Almudena Fuster-Matanzo, et al.
Cancer Letters|June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspectsBruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.
Pageof 13